Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ

Revenue (LTM)

Net Income (LTM)

$-30M

+23.8% YoY

Free Cash Flow

$-34M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	-1	0	0	0	0
Operating Income	-2	-10↓315.0%	-24↓140.6%	-40↓62.5%	-31↑22.0%
Net Income	-4	-9↓125.2%	-24↓185.6%	-39↓61.3%	-30↑23.8%
EBITDA	-2	-10↓333.9%	-24↓138.6%	-39↓62.6%	-30↑23.8%
EPS Diluted	-24.80	-11.60↑53.2%	-29.00↓150.0%	-33.00↓13.8%	-18.00↑45.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	9	30↑238.9%	19↓37.6%	23↑26.2%	13↓42.3%
Total Current Assets	9	31↑258.5%	19↓39.7%	24↑25.2%	15↓38.0%
Total Assets	9	31↑258.4%	19↓39.7%	24↑25.2%	16↓34.6%
Total Current Liabilities	1	2↑75.9%	10↑324.9%	17↑72.4%	15↓15.0%
Total Liabilities	3	3↓17.6%	11↑287.5%	18↑70.8%	15↓18.3%
Total Equity	5	29↑424.8%	8↓70.7%	6↓31.9%	1↓85.8%
Total Debt	0	0	0	0	0
Net Debt	-9	-30↓238.9%	-19↑37.6%	-23↓26.2%	-13↑44.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-4	-11↓162.3%	-19↓77.7%	-28↓49.4%	-34↓18.4%
Capital Expenditure	0	0	0	0	-0↓233.3%
Free Cash Flow	-4	-11↓162.3%	-19↓77.7%	-28↓49.4%	-34↓18.4%
Stock-Based Comp	0	0	0↑65.6%	3↑1831.3%	2↓52.2%
Net Change in Cash	9	21↑138.9%	-11↓153.4%	5↑143.4%	-10↓304.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance